These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2060561)

  • 1. Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.
    Lipworth BJ; Tregaskis BF; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(3):255-60. PubMed ID: 2060561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.
    Lipworth BJ; McDevitt DG; Struthers AD
    Br J Clin Pharmacol; 1989 Jun; 27(6):837-42. PubMed ID: 2547409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
    Crane J; Burgess C; Beasley R
    Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor responses to inhaled salbutamol in the elderly.
    Lipworth BJ; Tregaskis BF; McDevitt DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):725-9. PubMed ID: 2558701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
    Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
    Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.
    Marlin GE; Turner P
    Br J Clin Pharmacol; 1975 Feb; 2(1):41-8. PubMed ID: 10940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol.
    Lipworth BJ; McDevitt DG; Struthers AD
    Am J Med; 1989 Jun; 86(6 Pt 1):653-7. PubMed ID: 2729315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
    Scheinin M; Koulu M; Laurikainen E; Allonen H
    Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.
    Newnham DM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1993 Nov; 36(5):445-50. PubMed ID: 12959292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
    Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
    N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene.
    Lipworth BJ; McDevitt DG; Struthers AD
    Clin Sci (Lond); 1990 Mar; 78(3):255-9. PubMed ID: 2156644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.
    Rahman AR; McDevitt DG; Struthers AD; Lipworth BJ
    Thorax; 1992 Dec; 47(12):1056-9. PubMed ID: 1494770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.
    Lipworth BJ; McDevitt DG
    Eur J Clin Pharmacol; 1989; 36(3):239-45. PubMed ID: 2545455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical effects of high-dose inhaled salbutamol in patients with asthma.
    Lipworth BJ; Clark RA; Fraser CG; McDevitt DG
    Eur J Clin Pharmacol; 1989; 36(4):357-60. PubMed ID: 2737227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
    Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
    Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.
    Du Plooy WJ; Hay L; Kahler CP; Schutte PJ; Brandt HD
    Br J Pharmacol; 1994 Jan; 111(1):73-6. PubMed ID: 8012727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.